ReConstruct Bio Revenue
Biotechnology Research • 
Boston, Massachusetts, United States • 1-10 Employees
ReConstruct Bio revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at ReConstruct Bio
Luba Perry
Co-Founder and CEO
About ReConstruct Bio
ReConstruct Bio is an innovative venture emerging from Harvard’s Wyss Institute, aimed at redefining the fields of medical reconstruction and aesthetics. The initial application of our groundbreaking technology is in breast reconstruction and augmentation. With a multidisciplinary team of experts, we've developed the BioImplant—a living, bioengineered tissue created from the patient’s own cells. This innovation provides a safer, more natural alternative to current standards, which are often associated with significant drawbacks and health concerns.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
ReConstruct Bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
ReConstruct Bio has never raised funding before.
France
United Arab Emirates
Canada
Frequently asked questions
4.8
40,000 users
